Product Name | MF | CAS | Details |
---|
2H-Thieno[3,2-e]-1,2-thiazin-4-ol, 6-chloro-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)- | C10H14ClNO4S2 | 1413393-04-0 | Details |
2,5-Piperazinedione, 3-(1H-indol-3-ylmethyl)-1-methyl-, (3R)- | C14H15N3O2 | 1422164-53-1 | Details |
Benzamide, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-2-methyl-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]- | C22H16Cl2F6N2O3 | 1422465-94-8 | Details |
methyl 7-(benzyloxy)benzo[d][1,3]dioxole-5-carboxylate | C16H14O5 | 142531-43-9 | Details |
1,3-Benzodioxole-5-carboxylic acid, 4-bromo-7-(phenylmethoxy)-, methyl ester | C16H13BrO5 | 142531-44-0 | Details |
Methisosildenafil impure | C25H36N6O4S | 1425504-78-4 | Details |
(S)-methyl 2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate hydrochloride | C8H15ClN2O3 | 1429218-41-6 | Details |
PSQ-IM-B | C17H17N5O2 | 1430561-06-0 | Details |
Pixantrone maleate-004 | C17H17N5O2 | 1430561-08-2 | Details |
Benzamide, 2-bromo-6-fluoro-N-methyl- | C8H7BrFNO | 1436306-43-2 | Details |
Pixantrone Impurity B | C27H35N5O6 | 144510-94-1 | Details |
TPST-1120 | C35H39N5O3S | 1454925-59-7 | Details |
Olanexidine Impurity | 147028-65-7 | Details |
2-Propanol, 1-[[2-(2-methoxyphenoxy)ethyl]methylamino]-3-[(9-methyl-9H-carbazol-4-yl)oxy]- | C26H30N2O4 | 1479052-24-8 | Details |
mildronate-010 | C6H14N2O2 | 153050-92-1 | Details |
Ropivacaine impurity | C13H16N2O3 | 1543937-58-1 | Details |
3,4-Dibromo-5-methyl-benzoic acid | C8H6Br2O2 | 1564638-18-1 | Details |
N-(2,4-dimethylphenyl)piperidine-2-carboxamide | C14H20N2O | 1583238-33-8 | Details |
Medetomidine Impurity | C20H22N2O | 1587636-55-2 | Details |
Acetic acid, 2-(3-chloro-5-cyanophenoxy)-, ethyl ester | C11H10ClNO3 | 1613307-27-9 | Details |
synthesis-23 | C14H23ClN2O3S | 161449-05-4 | Details |
CINACALCET-001-R | C11H11BF4N4O | 1630761-22-6 | Details |
XGZZHZMWIXFATA-VQNNHZPYSA-N | C28H32N2O5 | 163712-68-3 | Details |
Ethanone, 1-(3-bromo-5-chlorophenyl)-2,2,2-trifluoro- | C8H3BrClF3O | 1655515-91-5 | Details |
3,3,5-trimethylcyclohexyl 2-oxo-2-phenylacetate | C17H22O3 | 16623-22-6 | Details |
Naltrexone Ethylene Ketal | C22H27NO5 | 16676-32-7 | Details |
Clevidipine Impurity 17 | C10H8Cl2O | 1685245-63-9 | Details |
Remdesivir-003-R | C9H19NO2 | 1689993-65-4 | Details |
2-Propenamide, N-(2-bromo-6-fluorophenyl)- | C9H7BrFNO | 1695869-28-3 | Details |
β-Alanine, N-(2-bromo-6-fluorophenyl)-, methyl ester | C10H11BrFNO2 | 1697691-31-8 | Details |
4-Bromo-n-methoxy-n,3-dimethylbenzamide | C10H12BrNO2 | 170230-01-0 | Details |
1-P-CHLOROPHENYL-1-CYCLOHEXANOL | C12H15ClO | 17380-83-5 | Details |
Ropivacaine-iPr | C17H26N2O | 175888-75-2 | Details |
mexidol-002 | C8H11NO | 1777826-23-9 | Details |
Articaine-012 | C10H13NO3S | 1779088-71-9 | Details |
Ropivacaine impurity | C13H16N2O3 | 1786518-57-7 | Details |
Ropivacaine impurity | C12H14N2O3 | 1786560-34-6 | Details |
Ropivacaine impurity | C12H14N2O3 | 1786841-18-6 | Details |
S-217622 | C14H14N2O.ClH | 1795692-55-5 | Details |
S-217622 | C17H19NO3SSi | 1809278-99-6 | Details |
AcotiaMide IMpurity 6 Maleate | C26H36N4O9S | 185103-81-5 | Details |
Benzoic acid, 4-bromo-3-methyl-, butyl ester | C12H15BrO2 | 1857027-20-3 | Details |
synthesis-022 | C41H67NO10 | 187170-37-2 | Details |
synthesis-20 | C13H26N2O2 | 1873303-87-7 | Details |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | C29H38ClN7O4 | 1883672-48-7 | Details |
S-217622 | C30H39N6O8P | 1884576-18-4 | Details |
2H-Indazol-5-amine, 6-bromo-2-methyl- | C8H8BrN3 | 1890002-53-5 | Details |
2-Thiophenecarboxylicacid,3-amino-4-methyl-,1-methylethylester(9CI) | C9H13NO2S | 190375-16-7 | Details |
ethyl 3-amino-4-methylthiophene-2-carboxylate | C8H11NO2S | 190375-17-8 | Details |
2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate | C21H23F5NO5P | 1911578-98-7 | Details |
3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imidazol-2(3H)-one) | C20H20Cl2N4O2 | 191977-79-4 | Details |
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one | C23H25F3N4O | 1971858-36-2 | Details |
3-O-Methylnaltrexone Ethylene Ketal | C23H29NO5 | 197242-23-2 | Details |
Acotiamide Impurity | C20H21N2NaO4S | 198470-83-6 | Details |
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C31H25F2N3O4S | 1985606-53-8 | Details |
1,6-2-HYDROXYBENZOYLAMINOHEXANE | C20H24N2O4 | 20073-95-4 | Details |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide | C13H19ClN4O3 | 2037385-84-3 | Details |
Tadalafil Impurity 39 | C21H17ClN2O5 | 2058231-08-4 | Details |
Bupivacaine IMpurity A | C14H21ClN2O | 205993-83-5 | Details |
Butylphthalide impurity | C12H13NO | 20871-40-3 | Details |
R-20 impurity 5 | C21H27N2O7P | 2093124-22-0 | Details |
2-ethylbutyl ((R)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate | C27H35N6O8P | 2093124-26-4 | Details |
R-18 | C9H20ClNO2 | 2096981-79-0 | Details |
R-19-impurity 4 | C21H27N2O7P | 2096985-18-9 | Details |
Remdesivir Impurity 44 | C27H35N6O8P | 2096990-00-8 | Details |
1H-Inden-1-one, 2,3-dihydro-3-hydroxy-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]- | C24H27NO4 | 2097683-70-8 | Details |
synthesis-15 | C21H15F4N5OS2 | 2110425-88-0 | Details |
W 36017 | C12H18N2O | 21236-54-4 | Details |
Benzenemethanesulfonic acid, 4-(methylamino)- (ACI) | C8H11NO3S | 2124221-11-8 | Details |
Bupivacaine Impurity | C18H28N2O | 2125994-25-2 | Details |
Bupivacaine Impurity | C18H28N2O | 2125995-24-4 | Details |
Bupivacaine Impurity | C18H28N2O | 2125995-26-6 | Details |
Bupivacaine Impurity | C18H28N2O.ClH | 2125995-27-7 | Details |
Bupivacaine Impurity | C18H28N2O.ClH | 2125995-28-8 | Details |
Levofloxacin-006-S | C20H23FN4O6 | 2130840-88-7 | Details |
Levofloxacin-007-S | C20H25FN4O4 | 2130840-90-1 | Details |
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate | C23H31N3O7S | 2136287-68-6 | Details |
Baloxavir Impurity 74 | C30H31F2N3O4S | 2136287-69-7 | Details |
Ethanone, 1-[3-chloro-4-fluoro-5-(trifluoromethyl)phenyl]-2,2,2-trifluoro- | C9H2ClF7O | 2138407-75-5 | Details |
4-(methoxycarbonyl)-1-naphthoic acid | C13H10O4 | 21426-90-4 | Details |
synthesis-11 | C9H10ClNO3S | 2169099-30-1 | Details |
2-Propenamide, N-(2-chloro-4-methylphenyl)-3-ethoxy- | C12H14ClNO2 | 2169776-07-0 | Details |
Ropivacaine-ET | C16H24N2O | 2180-94-1 | Details |
Dapagliflozin-022 | C23H29ClO8 | 2183515-32-2 | Details |
TERT-BUTYL [(1S)-1-(3-METHOXYPHENYL)ETHYL]CARBAMATE | C14H21NO3 | 218900-56-2 | Details |
Medetomidine Impurity 51 | C20H22N2 | 2197018-01-0 | Details |
S-217622 | C9H19NOS | 220315-20-8 | Details |
2-(Hydroxy(pyridin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one | C17H17NO4 | 2227606-37-1 | Details |
1H-Inden-1-one, 2,3-dihydro-2-(hydroxy-4-piperidinylmethyl)-5,6-dimethoxy- | C17H23NO4 | 2227606-39-3 | Details |
LeterMovir-004-salt-EA1 | C54H56F4N4O14 | 2241754-97-0 | Details |
Dapoxetine impurity | C28H26O3 | 2242008-36-0 | Details |
Dapoxetine impurity | C30H31NO2 | 2242008-37-1 | Details |
Dapoxetine-004 | C30H31NO | 2245197-07-1 | Details |
Remdesivir-001-LR | C21H23F5NO5P | 1911578-99-8 | Details |
Baricitinib Impurity 9 | C13H15N5O | 1911644-33-1 | Details |
INDEX NAME NOT YET ASSIGNED | C8H11F6N3O2 | 2248680-88-6 | Details |
Aripiprazole-002 | C12H13Cl2NO3 | 2250243-33-3 | Details |
Benzamide, N-[(1S)-2-amino-1-methyl-2-oxoethyl]-4-[(3-fluorophenyl)methoxy]- | C17H17FN2O3 | 2268802-59-9 | Details |
Propanedinitrile, 2-[2-(3-fluorophenyl)-2-oxoethyl]- | C11H7FN2O | 2304978-51-4 | Details |
Product Total: Product Page: | ||||
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 |